CRIS Current Research Information System

MIGLIOLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.859
EU - Europa 1.219
AS - Asia 676
AF - Africa 78
SA - Sud America 6
OC - Oceania 2
Totale 3.840
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.855
SG - Singapore 332
SE - Svezia 284
GB - Regno Unito 245
CN - Cina 230
IT - Italia 187
DE - Germania 158
IE - Irlanda 86
UA - Ucraina 57
BG - Bulgaria 55
IN - India 46
FR - Francia 41
CI - Costa d'Avorio 33
CH - Svizzera 29
TG - Togo 26
FI - Finlandia 25
VN - Vietnam 25
JO - Giordania 24
RU - Federazione Russa 24
ZA - Sudafrica 14
IR - Iran 11
EE - Estonia 9
JP - Giappone 7
BE - Belgio 5
BR - Brasile 4
CA - Canada 4
RO - Romania 4
SC - Seychelles 4
ES - Italia 3
NL - Olanda 3
AT - Austria 1
AU - Australia 1
CL - Cile 1
CZ - Repubblica Ceca 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
Totale 3.840
Salva come PNG Salva come JPEG
Città #
Singapore 298
Chandler 287
Santa Clara 242
Southend 203
Ashburn 117
Boardman 116
Fairfield 104
Princeton 97
Dublin 86
Ann Arbor 51
Sofia 51
Wilmington 49
Woodbridge 46
Berlin 42
Cambridge 42
Houston 42
Jacksonville 41
Seattle 37
Abidjan 33
Bern 28
Lomé 26
Amman 24
Bologna 24
Dong Ket 24
Helsinki 24
Nanjing 21
Milan 19
Guangzhou 18
Turin 18
Padova 16
Westminster 16
New York 14
Beijing 12
Falkenstein 10
San Diego 10
Los Angeles 8
Olalla 8
Shanghai 8
Jinan 7
Mountain View 7
Mülheim 7
Nanchang 7
Wuhan 7
Tokyo 6
Zhengzhou 6
Brussels 5
Medford 5
Saint Petersburg 5
Shenyang 5
Springfield 5
Washington 5
Boydton 4
Bremen 4
Changsha 4
Chongqing 4
Fort Worth 4
Frankfurt am Main 4
Fuzhou 4
Haikou 4
Hebei 4
London 4
Mahé 4
Shenzhen 4
Shijiazhuang 4
São Paulo 4
Taizhou 4
Campobasso 3
Cesenatico 3
Chiampo 3
Chicago 3
Dearborn 3
Dongying 3
Hangzhou 3
Kunming 3
Leawood 3
Monticelli 3
Nuremberg 3
Paris 3
Perugia 3
Phoenix 3
Redmond 3
Redwood City 3
Reggio Emilia 3
Tianjin 3
Verona 3
Zanjan 3
Amsterdam 2
Andover 2
Boves 2
Bronte 2
Brugherio 2
Bühl 2
Casalgrande 2
Costa Mesa 2
Hamburg 2
Jiaxing 2
Madrid 2
Naples 2
Napoli 2
Ningbo 2
Totale 2.537
Salva come PNG Salva come JPEG
Nome #
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 165
Erosions or not in GORD? The potential role of oesophageal cell proliferation 158
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 153
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 141
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 138
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 135
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 134
Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. 116
Erosions or not in GERD? The potential role of esophageal cell kinetics 109
The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. 109
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 108
Three-year experience in clinical intestinal transplantation 104
Diagnosi dell’infezione da Helicobacter pylori 102
Peptic ulcer and Helicobacter pylori. 97
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 97
Diagnosi non invasiva e terapia per Helicobacter Pylori 94
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 85
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 83
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 68
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 58
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 52
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 52
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis 51
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 50
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 47
Macrophage subpopulations in pouchitis 47
Bronchopulmonary involvement in ulcerative colitis 47
Role of rectal formulations: Enemas 44
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 44
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis 44
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 43
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 42
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils 42
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 41
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 41
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 41
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 41
Interleukin 1 in ulcerative colitis 40
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis 40
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 39
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 35
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis 35
Pentasa in maintenance treatment of ulcerative colitis 32
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 31
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 29
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 29
Systemic availability of 5-aminosalicylic acid: Comparison of delayed release and an azo-bond preparation 29
Rifaximin suspension for the eradication of helicobacter pylori 28
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 24
Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis 23
High eradication rates of Helicobacter pylori with a new sequential treatment 19
High eradication rates of Helicobacter pylori with a new sequential treatment 19
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 19
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 18
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 15
null 15
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 14
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 14
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 14
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 14
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 14
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 13
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 12
Helicobacter pylori and diminished growth in children: Is it simply a marker of deprivation? 12
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 11
Source of Helicobacter pylori Infection 10
Clinical significance of helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors 10
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 10
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 10
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 10
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 10
Treatment of symptom-free Helicobacter pylori-positive subjects 10
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 9
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 9
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 9
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 9
Symptoms and Helicobacter pylori: Any link [6] 9
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 9
Biliary surgery without the surgeon! 8
Helicobacter pylori and other spiral organisms in gastroduodenal disease 8
Susceptibility of Helicobacter pylori to Metronidazole 8
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 8
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 8
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 8
Optimal nutritional indexes in gastroenterology 8
Lipid peroxidation and antioxidant status in adults receiving lipid- based home parenteral nutrition 8
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 7
Review article: Diagnosis of Helicobacter pylori infection 7
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 7
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 7
Anti-CagA reactivity in Helicobacter pylori-negative subjects: A comparison of three different methods 7
Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection 7
Routes of trasmission of Helicobacter pylori infection 7
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 7
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia 7
Screening for Helicobacter pylori 6
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 6
IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients [17] 6
Helicobacter pylori: Diseases, tests and treatment 6
Source of Helicobacter pylori Infection 6
Totale 3.941
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020289 0 0 0 0 0 47 47 68 48 22 17 40
2020/2021220 51 19 7 12 10 17 2 12 14 15 14 47
2021/2022687 19 12 30 34 36 14 4 25 125 71 207 110
2022/20231.024 109 172 88 84 69 80 28 69 182 21 50 72
2023/2024444 96 66 30 60 32 83 12 23 3 23 7 9
2024/2025965 59 189 133 101 405 78 0 0 0 0 0 0
Totale 3.986